Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Strahlentherapie und Onkologie (Print)

• Publication date

  2008-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00066-008-1825-3PMID 18398584
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer: A multivariate study of 492 cases

  2010cited by this paper
• Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.

  2007cited by this paper
• Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

  2006cited by this paper
• Hyperfractionated-Accelerated Radiotherapy Followed by Radical Surgery in Locally Advanced Tumors of the Oral Cavity

  2006cited by this paper
• [Presentation of a 3D conformal radiotherapy technique for head-and-neck tumors resulting in substantial protection of the parotid glands].

  2006cited by this paper
• Religious Belief as a Coping Strategy

  2006cited by this paper
• First Experiences of Radiation Treatment Planning with PET/CT

  2006cited by this paper
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

  2005influential reference
• Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.

  2004cited by this paper
• Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial.

  2004cited by this paper
• Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.

  2004cited by this paper
• The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck.

  2003cited by this paper
• Salivary Gland Sparing and Improved Target Irradiation by Conformal and Intensity Modulated Irradiation of Head and Neck Cancer

  2003cited by this paper
• Multivariate Analysis of Prognostic Factors in 1 252 Consecutive Patients Treated with Primary Radiotherapy

  2003cited by this paper
• Prevalence of Anemia in Cancer Patients Undergoing Radiotherapy: Prognostic Significance and Treatment

  2002cited by this paper
• Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.

  2000influential reference
• Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas.

  2000cited by this paper
• 101 Impact of risk factors and total time for combined surgery and radiotherapy on the outcome of patients with advanced head and neck cancer

  1999cited by this paper
• Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.

  1998cited by this paper
• The impact on quality of life by radiation late effects.

  1995influential reference
• Tolerance of normal tissue to therapeutic irradiation.

  1991cited by this paper
• Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx.

  1991cited by this paper
• The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database.

  1991cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• World Workshop on Oral Medicine VIII: development of a core outcome set for dry mouth: A systematic review of outcome domains for xerostomia.

  2023cites this paper
• Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)

  2022cites this paper
• Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers

  2022cites this paper
• The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer

  2022cites this paper
• Prognostic Factors for Complete Recovery From Xerostomia After Radiotherapy of Head-and-Neck Cancers

  2022cites this paper
• Remediation of Mild, Acute Radiation Dermatitis Using a Stem Cell-Based Topical: A Real-World Case Report.

  2021cites this paper
• Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis

  2020cites this paper
• Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas

  2020cites this paper
• A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN).

  2019cites this paper
• Radiotherapy related skin toxicity (RAREST-02): A reminder app developed to reduce radiation dermatitis in patients with head-and-neck cancer

  2019cites this paper
• A New Phantom for Individual Verification of the Dose Distribution in Precision Radiotherapy for Head-and-Neck Cancer

  2019cites this paper
• Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer

  2018cites this paper
• Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort

  2018cites this paper
• Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with ≥42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer

  2018cites this paper
• Dendritic cells as therapeutic targets in neuroinflammation

  2016cites this paper
• Unconventional EGF-induced ERK1/2-mediated Kv1.3 endocytosis

  2016cites this paper
• Functional and pathological relevance of HERC family proteins: a decade later

  2016cites this paper
• Maintaining memory of silencing at imprinted differentially methylated regions

  2016cites this paper
• The predictive power of the desmo-adhesome

  2015cites this paper
• p53 regulates cytoskeleton remodeling to suppress tumor progression

  2015cites this paper
• Endoglin regulates mural cell adhesion in the circulatory system

  2015cites this paper
• Chemokines and microRNAs in atherosclerosis

  2015cites this paper
• Glycosyltransferase complexes in eukaryotes: long-known, prevalent but still unrecognized

  2015cites this paper
• Roles of connexins and pannexins in (neuro)endocrine physiology

  2015cites this paper
• Lymphoepithelial carcinoma of the salivary glands: case report of a rare cancer and review of the literature

  2014influential citation
• Adjuvant Low Single Dose Cisplatin-based Concurrent Radiochemotherapy of Oral Cavity and Oropharynx Carcinoma

  2011cites this paper
• High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma.

  2011cites this paper
• Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors

  2011cites this paper
• Survival of patients with head and neck cancer

  2011cites this paper
• Acute Arterial Hemorrhage Following Radiotherapy of Oropharyngeal Squamous Cell Carcinoma

  2010cites this paper
• Xerostomia in head and neck malignancy.

  2010cites this paper
• Brachial Plexopathy after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma

  2010cites this paper
• Outcome after Re-Irradiation of Head and Neck Cancer Patients

  2010cites this paper
• Reirradiation with Alternating Docetaxel-Based Chemotherapy for Recurrent Head and Neck Squamous Cell Carcinoma

  2010cites this paper
• Investigations on Parotid Gland Recovery after IMRT in Head and Neck Tumor Patients

  2010influential citation
• Osteonecrosis of the Jaws

  2010cites this paper
• A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life

  2010cites this paper
• Organ Function and Quality of Life after Transoral Laser Microsurgery and Adjuvant Radiotherapy for Locally Advanced Laryngeal Cancer

  2009cites this paper
• Current world literature.

  2009cites this paper
• High-Grade Acute Organ Toxicity During Preoperative Radiochemotherapy as Positive Predictor for Complete Histopathologic Tumor Regression in Multimodal Treatment of Locally Advanced Rectal Cancer*

  2009cites this paper
• Chemoradiotherapy with Weekly Cisplatin 40 mg/m2 in 103 Head-and-Neck Cancer Patients

  2009cites this paper
• Myofibroblastic Sarcoma of the Base of Tongue

  2009cites this paper